📰 Equal Life News
Equal Life News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Equal Life. Real-time updates on events, politics, business and more.
February 6, 2024
MONTREAL, Feb. 06, 2024 -- Knight Therapeutics Inc., , a Pan-American specialty pharmaceutical company, announced today the launch of BIJUVA® capsules in Canada. BIJUVA® is indicated for the...
December 14, 2023
Many patients experience impairment following a stroke, including motor or cognitive impairment, urinary incontinence, dysphagia...
December 11, 2023
First-in-class treatment option reduces number and intensity of hot flashes and night sweats TOKYO, Dec. 10, 2023 /PRNewswire/ -- Astellas Pharma Inc. today announced the European Commission on...
December 1, 2023
Phase 3b DAYLIGHT study being presented at ESG 2023 demonstrated fezolinetant 45 mg achieved statistically significant reductions in the frequency and severity of moderate to severe vasomotor symptoms due to menopause and patient-reported sleep disturbance at 24 weeks Women considered unsuitable included those with contraindications, who are averse to taking, have stopped taking or have conditions that suggest caution in using hormone therapy Results will support health technology a...
November 30, 2023
Phase 3b DAYLIGHT study being presented at ESG 2023 demonstrated fezolinetant 45 mg achieved statistically significant reductions in the frequency and severity...
October 13, 2023
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the Committee for Medicinal Products for Human...
September 18, 2023
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new pooled efficacy and safety analyses from the...
June 28, 2023
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the Phase 3b...
May 12, 2023
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA)...
May 12, 2023
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause TOKYO, May 12, 2023 /PRNewswire/ -- Astellas Pharma Inc. today... | June 14, 2023